PAROLE IN INGLESE ASSOCIATE CON «DOXORUBICIN»
doxorubicin
sigma
cardiotoxicity
side
effects
extravasation
shortage
dogs
mechanism
action
liposomal
doxorubicin
ˌdɒksəˈruːbəsɪn
also
known
hydroxydaunorubicin
drug
used
cancer
chemotherapy
derived
chemical
semisynthesis
from
bacterial
species
medlineplus
information
should
administered
only
into
vein
however
leak
surrounding
causing
severe
irritation
your
doctor
nurse
will
american
society
given
treat
hodgkin
lymphoma
multiple
myeloma
acute
leukemias
kaposi
sarcoma
ewing
wilm
tumor
adriamycin
macmillan
support
find
more
about
different
chemocare
anti
antineoplastic
cytotoxic
classified
antiobiotic
detail
intravenous
uses
interactions
pictures
patient
medical
webmd
safety
warnings
user
research
cancerhelp
type
called
slows
stops
growth
cells
that
drugbank
isolated
cultures
streptomyces
peucetius
caesius
binds
nucleic
acids
presumably
10 LIBRI IN INGLESE ASSOCIATI CON «DOXORUBICIN»
Scopri l'uso di
doxorubicin nella seguente selezione bibliografica. Libri associati con
doxorubicin e piccoli estratti per contestualizzare il loro uso nella letteratura.
1
DOXORUBICIN: ANTICANCER ANTIBIOTICS
Table II Activity of Doxorubicin Esters on Gross Leukemia in Mice at Optimal
Nontoxic Doses“ Dose" Compound (mg/kg) T/C Daunorubicin 3.25 176
Doxorubicin 2 187 Doxorubicin l4-acetate 2.5 168 Doxorubicin l4-propionate 4
147 ...
2
Advances in
Doxorubicin Research and Application: 2011 ...
Advances in Doxorubicin Research and Application: 2011 Edition is a ScholarlyPaper™ that delivers timely, authoritative, and intensively focused information about Doxorubicin in a compact format.
3
The Chemotherapy Source Book
Of the most widely used anthracycline antibiotics, doxorubicin and epirubicin
have a broad spectrum of activity against lymphomas, carcinomas, and sarcomas
whereas daunorubicin is utilized primarily in the treatment of acute leukemia.
Michael Clinton Perry, 2008
4
Principles and Practice of Gynecologic Oncology
Approximately 42% of the biliary drug is parent doxorubicin, 22% is doxorubicinol
. and 36% is other metabolites (183). Only 5% to 10% of the administered drug is
excreted in the urine as doxorubicin (40%), doxorubicinol (29%), and other ...
5
Withrow and MacEwen's Small Animal Clinical Oncology
Doxorubicin (Adriamycin PFS or RDF; Pharmacia & Upjohn, Bedford Labs; 10, 20
, and 50 mg single-dose vials); compared to other drugs, doxorubicin is
inexpensive and moderately toxic. Mechanism of Action Doxorubicin is an
anthracy- ...
Stephen J. Withrow, David M. Vail, 2007
6
Mechanisms and Management of
Doxorubicin-induced Cardiotoxicity
Doxorubicin (DOX), a topoisomerase II inhibitor that is commonly used to treat childhood and adult cancer, induces p53-mediated cardiomyocyte apoptosis and heart failure.
7
Drug Therapy in Nursing
mended maximum cumulative lifetime dose of doxorubicin is 550 mg/m2.
However, if the patient has previously had myocardial irradiation or cytotoxic drug
therapy, the cumulative lifetime dose should be lowered to 400 mg/m2. Modifying
the ...
Diane S. Aschenbrenner, Samantha J. Venable, 2009
Doxorubicin can be purchased in a pure powdered form (e.g., Handetech USA,
Inc., Houston, TX) or in a powder injectable form of 10, 50, and 150 mg of
doxorubicin-hydrochloride with 52.6, 263.1, and 789.4 mg lactose, respectively,
in each ...
9
Cancer Chemotherapy and Biotherapy: Principles and Practice
hereditary breast cancer susceptibility genes BRCA1 and 2 that par- ticipate in
repair of double-strand breaks in DNA, as produced by inhibition of top II.427
BRCA1 and 2 are initially up-regulated, then depleted by exposure to
doxorubicin in ...
Bruce A. Chabner, Dan L. Longo, 2010
10
Adult and Pediatric Urology
In the same study, randomized comparison of intravesical ethoglucid with
doxorubicin demonstrated a similar ability of both treatments to decrease
recurrences (181). Systemic side effects, such as myelosuppression, are less
common with ...
Jay Young Gillenwater, 2002
10 NOTIZIE DOVE SI INCLUDE IL TERMINE «DOXORUBICIN»
Vedi di che si parla nei media nazionali e internazionali e come viene utilizzato il termine ino
doxorubicin nel contesto delle seguenti notizie.
Less intensive chemo avoids irreversible side effects in children's …
The move follows the results of a Cancer Research UK trial, published in the Lancet today, showing that the drug doxorubicin can be safely ... «Cancer Research UK, lug 15»
Fear These Three Biotech Stocks - CTI BioPharma Corp (NASDAQ …
... (Zoptarelin Doxorubicin in Endometrial Cancer) clinical study with zoptarelin doxorubicin in women with advanced, recurrent or metastatic endometrial cancer. «Wall Street Observer, lug 15»
CytRx Stock Rating Upgraded by Zacks (CYTR)
Aldoxorubicin, formlerly INNO-206 is a tumor-targeted doxorubicin conjugate. Aldoxorubicin has been granted orphan drug designation by the ... «WKRB News, lug 15»
Investors Dumping 3 Biotech Stocks - Juno Therapeutics Inc …
... (Zoptarelin Doxorubicin in Endometrial Cancer) clinical study with zoptarelin doxorubicin in women with advanced, recurrent or metastatic endometrial cancer. «Wall Street Observer, lug 15»
Mary Tankersley's Declaration of Independence: Childhood Cancer …
... hospital receiving a chemotherapy cocktail containing methotrexate, cisplatin and doxorubicin; drugs that are all part of our outdated arsenal. «Huffington Post, lug 15»
Interim PET/CT Not Useful for DLBCL
... value to patients with diffuse large B-cell lymphoma (DLBCL) being treated with R-CHOP-14 (rituximab plus cyclophosphamide, doxorubicin, ... «Cancer Network, lug 15»
Could BEACOPP Regimen Work Without Bleomycin, Vincristine?
According to the study, the role of bleomycin and vincristine as part of the BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, ... «Cancer Network, lug 15»
3 Biotech Stocks Are Getting Crushed - Prima Biomed Ltd …
... (Zoptarelin Doxorubicin in Endometrial Cancer) clinical study with zoptarelin doxorubicin in women with advanced, recurrent or metastatic endometrial cancer. «Wall Street Observer, lug 15»
Active Stocks News Analysis: AEterna Zentaris Inc. (USA) (NASDAQ …
AEterna Zentaris Inc., declared it has reached its aim of recruiting 500 patients for its pivotal Phase 3 ZoptEC (Zoptarelin Doxorubicin in ... «wsnewspublishers, lug 15»
RING finger protein 31 promotes p53 degradation in breast cancer …
The MDM2 antagonist nutlin-3 sensitizes p53-null neuroblastoma cells to doxorubicin via E2F1 and TAp73. Int J Oncol 2009; 34: 1395–1402. «Nature.com, lug 15»
